Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice?

Sadique, MZ; Grieve, R; Harrison, DA; Cuthbertson, BH; Rowan, KM; (2011) Is Drotrecogin alfa (activated) for adults with severe sepsis, cost-effective in routine clinical practice? Critical care (London, England), 15 (5). R228. ISSN 1364-8535 DOI: https://doi.org/10.1186/cc10468

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1186/cc10468

Abstract

Share

Download

Filename: cc10468.pdf

Licence: Creative Commons: Attribution 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar